FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffery Hobden

Research Profile

Disorders

Living Beings

Anatomy

Cornea

Procedures

Chemicals & Drugs

Concepts & Ideas

Virulence

Physiology

Bacterial Adhesions

Co-author Network

Publications

TOP 3
Marsha R Cole; Bilal El-Zahab; Daniel Hayes; Jeffery A Hobden; Ravirajsinh Jadeja; Marlene E Janes; Min Li; Isiah M Warner
Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.
Jeffery A Hobden; Manish Kumar; Herbert E Kaufman; Christian Clement; Emily D Varnell; Partha S Bhattacharjee; James M Hill
In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.
Christian Clement; Joseph A Capriotti; Manish Kumar; Jeffery A Hobden; Timothy P Foster; Partha S Bhattacharjee; Hilary W Thompson; Rashed Mahmud; Bo Liang; James M Hill
Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffery Hobden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marsha R Cole; Bilal El-Zahab; Daniel Hayes; Jeffery A Hobden; Ravirajsinh Jadeja; Marlene E Janes; Min Li; Isiah M Warner
Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.
The Journal of antimicrobial chemotherapy 2013;68(6):1312-8.
2011: Jeffery A Hobden; Manish Kumar; Herbert E Kaufman; Christian Clement; Emily D Varnell; Partha S Bhattacharjee; James M Hill
In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.
Investigative ophthalmology & visual science 2011;52(2):830-3.
2011: Christian Clement; Joseph A Capriotti; Manish Kumar; Jeffery A Hobden; Timothy P Foster; Partha S Bhattacharjee; Hilary W Thompson; Rashed Mahmud; Bo Liang; James M Hill
Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Investigative ophthalmology & visual science 2011;52(1):339-44.
2010: Priyanka Karicherla; Siddhesh Aras; Ashok Aiyar; Jeffery A Hobden
Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis.
Cornea 2010;29(11):1308-14.
2010: Priyanka Karicherla; Jeffery A Hobden
Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis.
Current eye research 2010;35(3):220-4.
2009: Priyanka Karicherla; Jeffery A Hobden
Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Investigative ophthalmology & visual science 2009;50(1):256-62.
2007: Clare C McCormick; Jeffery A Hobden; C L Balzli; Julian M Reed; Armando R Caballero; B S Denard; A Tang; Richard J O'Callaghan
Surfactant protein D in Pseudomonas aeruginosa keratitis.
Ocular immunology and inflammation 2007;15(5):371-9.
2005: Quinn M Parks; Jeffery A Hobden
Polyphosphate kinase 1 and the ocular virulence of Pseudomonas aeruginosa.
Investigative ophthalmology & visual science 2005;46(1):248-51.
2004: Archana Thakur; Ronald Barrett; Jeffery A Hobden; Linda D Hazlett
Caspase-1 inhibitor reduces severity of pseudomonas aeruginosa keratitis in mice.
Investigative ophthalmology & visual science 2004;45(9):3177-84.
2003: Jeffery A Hobden
Intercellular adhesion molecule-2 (ICAM-2) and Pseudomonas aeruginosa ocular infection.
DNA and cell biology 2003;22(10):649-55.
2003: Brigitte A Cowell; Sally S Twining; Jeffery A Hobden; Mary S F Kwong; Suzanne M J Fleiszig
Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells.
Microbiology (Reading, England) 2003;149(Pt 8):2291-9.
2002: Jeffery A Hobden
Pseudomonas aeruginosa proteases and corneal virulence.
DNA and cell biology 2002;21(5-6):391-6.
2002: Christopher M Pillar; Jeffery A Hobden
Pseudomonas aeruginosa exotoxin A and keratitis in mice.
Investigative ophthalmology & visual science 2002;43(5):1437-44.
2001: C D White; LG Alionte; Bennetta M Cannon; Armando R Caballero; Richard J O'Callaghan; Jeffery A Hobden
Corneal virulence of LasA protease--deficient Pseudomonas aeruginosa PAO1.
Cornea 2001;20(6):643-6.
2001: LG Alionte; Bennetta M Cannon; C D White; Armando R Caballero; Richard J O'Callaghan; Jeffery A Hobden
Pseudomonas aeruginosa LasA protease and corneal infections.
Current eye research 2001;22(4):266-71.
2000: C M Pillar; Linda D Hazlett; Jeffery A Hobden
Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
Current eye research 2000;21(3):730-9.
2000: P S Estrellas; LG Alionte; Jeffery A Hobden
A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
Current eye research 2000;20(3):157-65.
2000: Karen A Kernacki; Ronald Barrett; Jeffery A Hobden; Linda D Hazlett
Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):1037-45.
1999: Jeffery A Hobden; S Masinick-McClellan; Ronald Barrett; K S Bark; Linda D Hazlett
Pseudomonas aeruginosa keratitis in knockout mice deficient in intercellular adhesion molecule 1.
Infection and immunity 1999;67(2):972-5.
1998: Brigitte A Cowell; Mark D P Willcox; Jeffery A Hobden; Rene P Schneider; Simon D Tout; Linda D Hazlett
An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model.
Experimental eye research 1998;67(3):347-56.
1998: L Chen; Jeffery A Hobden; SA Masinick; Linda D Hazlett
Environmental factors influence P. aeruginosa binding to the wounded mouse cornea.
Current eye research 1998;17(3):231-7.
1998: Lee S Engel; James M Hill; Judy M Moreau; LC Green; Jeffery A Hobden; Richard J O'Callaghan
Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Investigative ophthalmology & visual science 1998;39(3):662-5.
1997: Lee S Engel; Jeffery A Hobden; Judy M Moreau; M C Callegan; James M Hill; Richard J O'Callaghan
Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
Investigative ophthalmology & visual science 1997;38(8):1535-42.
1997: Jeffery A Hobden; SA Masinick; Ronald Barrett; Linda D Hazlett
Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.
Infection and immunity 1997;65(7):2754-8.
1996: S K Gupta; SA Masinick; Jeffery A Hobden; Richard S Berk; Linda D Hazlett
Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea.
Experimental eye research 1996;62(6):641-50.
1996: Jeffery A Hobden; S K Gupta; SA Masinick; X Wu; Karen A Kernacki; Richard S Berk; Linda D Hazlett
Anti-receptor antibodies inhibit Pseudomonas aeruginosa binding to the cornea and prevent corneal perforation.
Immunology and cell biology 1996;74(3):258-64.
1996: Richard J O'Callaghan; Lee S Engel; Jeffery A Hobden; M C Callegan; LC Green; James M Hill
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
Investigative ophthalmology & visual science 1996;37(4):534-43.
1995: Karen A Kernacki; Jeffery A Hobden; Linda D Hazlett; Rafael Fridman; Richard S Berk
In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
Investigative ophthalmology & visual science 1995;36(7):1371-8.
1995: Jeffery A Hobden; SA Masinick; Ronald Barrett; Linda D Hazlett
Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.
Investigative ophthalmology & visual science 1995;36(6):1107-14.
1995: M K Johnson; M C Callegan; Lee S Engel; Richard J O'Callaghan; James M Hill; Jeffery A Hobden; G J Boulnois; P W Andrew; Tim Mitchell
Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea.
Current eye research 1995;14(4):281-4.
1995: Lee S Engel; M C Callegan; Jeffery A Hobden; J J Reidy; James M Hill; Richard J O'Callaghan
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Current eye research 1995;14(3):229-34.
1993: Jeffery A Hobden; James M Hill; Lee S Engel; Richard J O'Callaghan
Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
Antimicrobial agents and chemotherapy 1993;37(9):1856-9.
1993: Jeffery A Hobden; Lee S Engel; James M Hill; M C Callegan; Richard J O'Callaghan
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.
Current eye research 1993;12(5):469-73.
1993: Jeffery A Hobden; Lee S Engel; M C Callegan; James M Hill; Bryan M Gebhardt; Richard J O'Callaghan
Pseudomonas aeruginosa keratitis in leukopenic rabbits.
Current eye research 1993;12(5):461-7.
1993: Jeffery A Hobden; Richard J O'Callaghan; M S Insler; James M Hill
Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis.
Cornea 1993;12(2):138-41.
1993: James M Hill; Jeffery A Hobden; W G Liu; Rong Wen; X Zhang; M C Callegan
Ocular antivirals.
International ophthalmology clinics 1993;33(4):69-80.
1992: M K Johnson; Jeffery A Hobden; Richard J O'Callaghan; James M Hill
Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Current eye research 1992;11(12):1221-5.
1992: M C Callegan; James M Hill; M S Insler; Jeffery A Hobden; Richard J O'Callaghan
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Current eye research 1992;11(11):1111-9.
1992: T E Clinch; Jeffery A Hobden; J M Hill; Richard J O'Callaghan; Lee S Engel; H E Kaufmann
Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc 1992;18(4):245-7.
1992: M C Callegan; Jeffery A Hobden; James M Hill; M S Insler; Richard J O'Callaghan
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Investigative ophthalmology & visual science 1992;33(11):3017-23.
1992: Jeffery A Hobden; Richard J O'Callaghan; James M Hill; M Hagenah; M S Insler; J J Reidy
Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
Current eye research 1992;11(3):259-65.
1992: E B Brockman; P A Tarantino; Jeffery A Hobden; J M Hill; Richard J O'Callaghan; H E Kaufman; M S Insler
Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Refractive & corneal surgery 1992;8(1):39-43.
1991: M S Insler; L A Fish; J Silbernagel; Jeffery A Hobden; Richard J O'Callaghan; J M Hill
Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin.
Ophthalmology 1991;98(11):1690-2.
1991: J J Reidy; Jeffery A Hobden; James M Hill; K Forman; Richard J O'Callaghan
The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Cornea 1991;10(1):25-8.
1990: Jeffery A Hobden; J J Reidy; Richard J O'Callaghan; M S Insler; James M Hill
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Investigative ophthalmology & visual science 1990;31(11):2241-3.
1990: M K Johnson; Jeffery A Hobden; M Hagenah; Richard J O'Callaghan; James M Hill; S Chen
The role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Current eye research 1990;9(11):1107-14.
1990: Jeffery A Hobden; J J Reidy; Richard J O'Callaghan; M S Insler; James M Hill
Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.
Investigative ophthalmology & visual science 1990;31(10):1940-4.
1989: Jeffery A Hobden; Richard J O'Callaghan; James M Hill; J J Reidy; D S Rootman; Hilary W Thompson
Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
Current eye research 1989;8(11):1163-9.
1988: Jeffery A Hobden; J J Reidy; Richard J O'Callaghan; James M Hill; M S Insler; D S Rootman
Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
Archives of ophthalmology 1988;106(11):1605-7.
1988: Jeffery A Hobden; D S Rootman; Richard J O'Callaghan; James M Hill
Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.
Antimicrobial agents and chemotherapy 1988;32(7):978-81.
1988: D S Rootman; Jeffery A Hobden; J A Jantzen; J R Gonzalez; Richard J O'Callaghan; James M Hill
Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
Archives of ophthalmology 1988;106(2):262-5.